CME Group Inc. (NASDAQ:CME) Shares Sold by Cambiar Investors LLC

Cambiar Investors LLC lowered its position in shares of CME Group Inc. (NASDAQ:CME) by 1.2% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 284,702 shares of the financial services provider’s stock after selling 3,433 shares during the quarter. CME Group accounts for about 2.4% of Cambiar Investors LLC’s investment portfolio, making the stock its 3rd biggest holding. Cambiar Investors LLC owned about 0.08% of CME Group worth $62,819,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Keystone Financial Planning Inc. boosted its holdings in shares of CME Group by 1.6% in the third quarter. Keystone Financial Planning Inc. now owns 35,235 shares of the financial services provider’s stock valued at $7,775,000 after buying an additional 559 shares during the period. Hartford Financial Management Inc. boosted its holdings in shares of CME Group by 8.5% in the third quarter. Hartford Financial Management Inc. now owns 8,752 shares of the financial services provider’s stock valued at $1,931,000 after buying an additional 688 shares during the period. Manitou Investment Management Ltd. boosted its holdings in shares of CME Group by 7.1% in the third quarter. Manitou Investment Management Ltd. now owns 3,060 shares of the financial services provider’s stock valued at $675,000 after buying an additional 203 shares during the period. HM Payson & Co. boosted its holdings in shares of CME Group by 33.6% in the third quarter. HM Payson & Co. now owns 962 shares of the financial services provider’s stock valued at $212,000 after buying an additional 242 shares during the period. Finally, Goldstone Financial Group LLC acquired a new position in shares of CME Group in the third quarter valued at approximately $1,265,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Insider Activity

In related news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares in the company, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares in the company, valued at $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Timothy S. Bitsberger sold 1,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $226.96, for a total transaction of $226,960.00. Following the completion of the sale, the director now owns 10,589 shares in the company, valued at approximately $2,403,279.44. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,221 shares of company stock valued at $3,351,895 over the last ninety days. 0.30% of the stock is currently owned by company insiders.

CME Group Price Performance

Shares of CME opened at $223.61 on Friday. The firm has a market capitalization of $80.52 billion, a PE ratio of 23.51, a PEG ratio of 5.72 and a beta of 0.55. The company’s 50-day moving average is $220.69 and its 200-day moving average is $209.46. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $230.36. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The company’s revenue was up 18.4% on a year-over-year basis. During the same period in the prior year, the firm earned $2.25 earnings per share. Equities analysts forecast that CME Group Inc. will post 10.23 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th were given a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.06%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is presently 48.37%.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on CME. TD Cowen assumed coverage on shares of CME Group in a report on Thursday, September 26th. They issued a “hold” rating and a $221.00 price target for the company. JPMorgan Chase & Co. boosted their price objective on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Piper Sandler boosted their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research report on Monday, October 28th. Royal Bank of Canada reissued a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research report on Thursday, October 24th. Finally, Barclays boosted their price objective on shares of CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 24th. Four analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, CME Group has an average rating of “Hold” and a consensus price target of $222.73.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.